Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

Uwe Haberkorn; Maria Reinhardt; Ludwig G. Strauss; Franz Oberdorfer; Martin R. Berger; Annette Altmann; Reinhard Wallich; Antonia Dimitrakopoulou; Gerhard van Kaick

Research ArticleLaboratory Studies

Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou and Gerhard van Kaick

Journal of Nuclear Medicine November 1992, 33 (11) 1981-1987;

Uwe Haberkorn

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Reinhardt

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ludwig G. Strauss

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Franz Oberdorfer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin R. Berger

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Annette Altmann

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Reinhard Wallich

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Antonia Dimitrakopoulou

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerhard van Kaick

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 33, Issue 11

November 1, 1992

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou, Gerhard van Kaick

Journal of Nuclear Medicine Nov 1992, 33 (11) 1981-1987;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou, Gerhard van Kaick

Journal of Nuclear Medicine Nov 1992, 33 (11) 1981-1987;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Treatment of Breast Tumor Cells In Vitro with the Mitochondrial Membrane Potential Dissipater Valinomycin Increases 18F-FDG Incorporation
Assessment of Treatment Response by Autoradiography with 14C-Aminocyclopentane Carboxylic Acid, 67Ga-DTPA, and 18F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model
2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome

Google Scholar

Main menu

User menu

Search

Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles